companydata.dkPharmaforce ApS: Financial statements 2023
CVR: 26394198
Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,682,481 and a net result of DKK 262,216 compared with DKK 282,708 the year before. That is an increase of 1.2% compared with the year before. Equity amounted to DKK 2,920,295. The solvency ratio was 61%. The company had 5 employees in the financial year.
- Gross Profit
- 3,682,481 kr.
- Profit/Loss
- 262,216 kr.
- Equity
- 2,920,295 kr.
- Total Assets
- 4,786,600 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3.7 mio. | 262 t. | 2.9 mio. | 5 |
| 2022 | - | 3.6 mio. | 283 t. | 2.9 mio. | 5 |
| 2021 | - | 4.2 mio. | 367 t. | 2.9 mio. | 5 |
| 2020 | - | 4.3 mio. | 1.1 mio. | 2.5 mio. | 5 |
| 2019 | - | 2.8 mio. | 264 t. | 1.4 mio. | 4 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmaforce ApS has published its annual report for 2022. Gross profit came to DKK 3,639,952, and the net result was DKK 282,708.
About Pharmaforce ApS
Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.